In this episode of “The Top Line,” we explore the growing space of biopharma prediction markets, how they work and the risks they create around insider information and clinical trial integrity.
In this episode of “The Top Line,” we explore the growing space of biopharma prediction markets, how they work and the risks they create around insider information and clinical trial integrity.